Monica Shaw, SVP Global Oncology Commercialization and General Manager US at Bristol Myers Squibb, shared a post on LinkedIn:
“We often talk about progress in oncology in terms of speed: how quickly innovation moves from discovery to patients. But in a landscape that’s becoming more complex, I’ve been reflecting on whether speed alone is the right measure.
Clinicians today are navigating more data, more options, and more decisions in real time. That shift is changing what progress looks like in practice.
I shared a longer reflection on this, including how an experience in Patagonia shaped my thinking-and how it connects to our Time Back work at Bristol Myers Squibb.
I’d be interested in your perspective: how do you define progress in oncology today?”
Other articles featuring Monica Shaw on OncoDaily.